There is a strong general belief that screening tests and checkups
are important elements in improving health for individuals and also good for
the greater public. However a recent comprehensive review published by the Cochrane Library, on the value of general health checkups, questions the value of such regular exams. At the same time, there are ongoing debates
about the specifics of screening tests.
Some of the recent controversies concerning the proper age to begin screening
mammography for breast cancer and use of PSA blood tests in screening for
Prostate Cancer underscore these debates. Combine all this controversy about
specific tests and add in this large study questioning the basic philosophy of
regular checkups and screening and you get some massive confusion. It is reasonable to ask why we argue about
these details of screening if, according to the Cochrane study it is all
worthless anyway!
My writing about this started out quite simply as a way of
bringing a change in the screening recommendations for Chronic Hepatitis C
infection to people’s attention. In
August of this year, the CDC published a recommendation that all people born between the years 1945 and 1965 (aged 47-67) should have a one-time test for chronic Hepatitis C. This represented an
addition to previous recommendations from the CDC for people of all ages who
fit certain risk groups, such as a prior history of IV drug abuse or a being a
physician or nurse to be screened. Due
to my compulsive nature, I decided to also look at the recommendations of the UnitedStates Preventive Services Task Force (USPSTF).
This independent body under the auspices of the Agency for Health
Research and Quality (AHRQ) which is part of the Department of Health and Human
Services is an arbiter of recommendations concerning screening tests. The CDC on the other hand is a part of the
Department of Health and Human Services and is not an independent body. To my surprise I found that the USPSTF had a
different recommendation than the CDC.
This was explained in the CDC article published in the Annals of Internal Medicine that recommended the broader
screening for Hepatitis C. It said:
The U.S. Preventive Services Task Force (USPSTF)
and the CDC both issue preventive recommendations using evidence-based methods
that include evaluating available data on a topic and drawing conclusions on
the basis of the strength of the evidence. However, several differences exist
between the organizations, including their affiliation, target audience, and
scope. ....... The
USPSTF focuses on the primary care setting and provider-patient interactions
and considers the harms and benefits (generally, reduced morbidity and
mortality) to the patient directly resulting from a given intervention. The CDC
has a broader public health focus that includes diverse settings outside of
primary care and considers not only the benefits and harms of an intervention
but also the potential harms of an absence of public health action and of future
transmission of disease.
The USPSTF's HCV screening recommendations and the CDC's birth cohort recommendation are not in direct conflict, and updated USPSTF recommendations are expected within a year. In 2004, the USPSTF found insufficient evidence to recommend for or against HCV screening among high-risk persons (for example, persons who have ever injected drugs) and against routine testing for all asymptomatic adults ( 39). The CDC's recommendation for 1-time HCV testing is only for persons born during 1945 to 1965, not for all adults. The CDC's recommendation is, to a large degree, built upon an intermediate measure (SVR) and its strong association with reductions in HCC and all-cause mortality.
The USPSTF's HCV screening recommendations and the CDC's birth cohort recommendation are not in direct conflict, and updated USPSTF recommendations are expected within a year. In 2004, the USPSTF found insufficient evidence to recommend for or against HCV screening among high-risk persons (for example, persons who have ever injected drugs) and against routine testing for all asymptomatic adults ( 39). The CDC's recommendation for 1-time HCV testing is only for persons born during 1945 to 1965, not for all adults. The CDC's recommendation is, to a large degree, built upon an intermediate measure (SVR) and its strong association with reductions in HCC and all-cause mortality.
Are you now clear on what screening for
Hepatitis C should be done? So what do you
do? Who do you follow? Should you follow the recommendations of the
CDC, the USPSTF or in the case of other screening recommendations some other group such as the American Cancer Society or the
American Heart Association? Or should
you, following the Cochrane report, just ignore all of them and give up on regular checkups and the screening that accompanies them?
The Cochrane report was comprehensive. They reviewed
16 studies, 14 of which had outcome data on 182,880 people. To quote their conclusion,
“General health checks did not reduce morbidity or mortality,
neither overall nor for cardiovascular or cancer causes, although the number of
new diagnoses was increased…….With the large number of participants and deaths
included, the long term follow-up periods used, and considering that
cardiovascular and cancer mortality were not reduced, general health chicks are
unlikely to be beneficial.”
What is going on here? How
is an individual to decide what to do?
The reality is that the image of certainty that pervades the
public perception of health care is faulty.
Good health care is really riddled with uncertainly and is dependent on
a careful assessment of the balance between the risks and benefits of a
particular test or therapy for a particular individual at a particular point in
time. While screening tests and
procedures and general check-ups are supposed to be independent of those
individual variables as they are recommended for broad segments of the
population the decision to undergo screening is often not so straightforward.
The definition of screening is “A test or procedure performed for
a patient who does not have symptoms, abnormal findings or any past history of
a disease in order to detect an unsuspected and undiagnosed disease so that
medical treatment can begin.” The timing
and frequency of such a test is usually defined in the screening
recommendation, such as the timing for a Hepatitis C test as being once anytime
for a person aged 47 to 67 or the timing for mammography being yearly for women over 40 or 50 depending on
which screening recommendation you follow.
They are supposed to be for everyone defined under the screening
criteria. A general checkup as studied
in the Cochrane Library review is one type of screening exam and often includes
many of the tests and procedures covered under the detailed recommendations.
The reality that is often ignored in all these studies and all
these recommendations is that a person often decides to see a physician for a
“general checkup” because they are not feeling well, sometimes in a very
non-specific and vague way. Perhaps they
are just feeling a bit sluggish or weak; perhaps they have gained or lost some
weight. The good physician then takes a
history to try and pull from the patient the information to better define how
they are really feeling. The tests and
procedures may then be considered diagnostic and not screening however how they
are recorded becomes a function of payment and insurance, not of clinical
analysis. The insurance data bases that
many of these studies use for clinical analysis code the exam in the way it is submitted by the
health professional and that may be preventive or screening because under
today’s rules, that is often paid at a higher rate. It is hard to say how those very common
situations of vague reasons driving the regular exam fit into the data on specific screening tests or on general
checkups.
So as for me, I will continue to see my doctor once a year. As for Hepatitis C, I will have one time
testing as I fit into the age category and into the high risk category,
especially because while in practice I specialized in gastroenterology and came
in contact with large numbers of people with liver disease. My recommendation to you is to always be an
active participant in your care. Regardless
of the statistical benefit of a routine checkup, a good relationship with a
doctor who you can call on in time of need is always a good thing. It may take a general checkup to develop such
a relationship. Determine your own
particular risks and your own values and beliefs in making decisions about your own care including decisions about screening. Then
make your own decision based on all of the facts. What makes sense for a
population may or may not make sense for you as an individual at a particular
point in time.
No comments:
Post a Comment